Skip to main content
Clinical Trials/IRCT20210307050610N1
IRCT20210307050610N1RecruitingPhase 3

Investigation the effect of the 24 and 48-hour changing in chloride sodium 0.9% used in infusion of drug on the amount of phlebitis and serum infection

Sabzevar University of Medical Sciences0 sites300 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 3
Status
Recruiting
Sponsor
Enrollment
300

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 years to no limit (—)
Sex
All

Inclusion Criteria

  • People over the age of 18
  • patient consent or caregiver
  • patient cooperation
  • having a drug to be infused
  • patients who have been hospitalized for at least 48 hours

Exclusion Criteria

  • Pregnant patients
  • lactating patients
  • immunocompromised patients
  • Patients with skin and vascular diseases
  • Patients receiving hypertonic serum
  • and patients receiving blood and blood products
  • patients receivingTotal parenteral nutrition
  • Patients with sepsis
  • patients with mental disorders
  • Patients receiving anticoagulants
  • If you have a local infection at the catheter injection site

Investigators

Sponsor
Sabzevar University of Medical Sciences

Similar Trials